<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.diabesityrounds.com/a/fda-approves-once-weekly-insulin-awiqli-for-children-with-type-2-diabetes</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-23T20:32:11.115Z</news:publication_date><news:title>FDA approves once-weekly insulin Awiqli for children with type 2 diabetes</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/retatrutide-cut-sleep-apnoea-severity-more-than-placebo-in-two-phase-3-trials</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-23T20:17:48.717Z</news:publication_date><news:title>Retatrutide cut sleep apnoea severity more than placebo in two phase 3 trials</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/cdsco-expert-committee-trial-permission-recommended-for-oral-semaglutide-3-more</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-23T20:02:00.346Z</news:publication_date><news:title>CDSCO expert committee: trial permission recommended for oral semaglutide, 3 more</news:title></news:news></url></urlset>